Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Operating Expenses | 44,215 | 0 | 33,151 | 29,746 | 29,093 |
| Operating Income | -44,215 | N/A | -33,151 | -29,746 | -29,093 |
| Other Income | 3,772 | 0 | 4,123 | 2,096 | 3,776 |
| Pre-tax Income | -40,443 | 0 | -29,028 | -27,650 | -25,317 |
| Net Income Continuous | -40,443 | N/A | -29,028 | -27,650 | -25,317 |
| Net Income | $-40,443 | $N/A | $-29,028 | $-27,650 | $-25,317 |
| EPS Basic Total Ops | -0.87 | N/A | -0.84 | -0.80 | -0.74 |
| EPS Basic Continuous Ops | -0.87 | N/A | -0.84 | -0.80 | -0.74 |
| EPS Diluted Total Ops | -0.87 | N/A | -0.84 | -0.80 | -0.74 |
| EPS Diluted Continuous Ops | -0.87 | N/A | -0.84 | -0.80 | -0.74 |
| EBITDA(a) | $-44,215 | $N/A | $-32,466 | $-28,326 | $-29,093 |